Sort
82,697 grants matching “vaccine development”
Development of highly potent human monoclonal for RSV immunoprophylaxis
$993,353Ellen Monson · Mapp Biopharmaceutical, Inc. · SB1 · FY2025 · AI
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$993,273Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine
$993,161Kenneth C Bagley · Profectus Biosciences, Inc. · R44 · FY2018 · AI
Attenuated Sporozoite Malaria Vaccine
$992,988Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2010 · AI
Towards a New Generation of Glycoengineered Pneumococcal Bioconjugate Vaccines
$992,959Christian Harding · Vaxnewmo, Llc · R44 · FY2021 · AI
SDMC: HIV Vaccine Trials Network
$992,886Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Acute Hepatitis C Infection in Young Injectors
$992,772Kimberly Page · University Of California, San Francisco · R01 · FY2011 · DA
A human cytomegalovirus-based immunotherapy for HIV-1
$992,696Eric Bruening · Tomegavax, Inc. · R44 · FY2014 · AI
Development of a Yellow Fever Vaccine for Vulnerable Population
$992,669Ian James Amanna · Najit Technologies, Inc. · R44 · FY2012 · AI
Genital Herpes Vaccine Discovery
$992,626Gary Fujii · Molecular Express, Inc. · R44 · FY2008 · AI
Nonhuman Primate
$992,607Michael K Axthelm · Oregon Health & Science University · P01 · FY2014 · AI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
$992,504Jiang Zhu · Scripps Research Institute, The · R01 · FY2019 · AI
Bio-Therapies for the Treatment of Cancer and Infectious Disease
$992,485David Fitzgerald · Basic Sciences · Z01 · FY2007 · CA
Host Immune Responses to Antigens of Malaria Parasites
$992,457Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Malaria Pathogenesis and Human Immunity
$992,443Rick Fairhurst · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Preclinical development of a potent D-peptide RSV inhibitor
$992,263Brett D Welch · Navigen, Inc. · R44 · FY2016 · AI
Development of Novel Immunogens for Vaccines to HIV-1
$992,252Robert Gerald Whalen · Altravax, Inc. · P01 · FY2009 · AI
Institute of Human Virology Clinical Trials Unit
$992,201William Albert Blattner · University Of Maryland Baltimore · U01 · FY2008 · AI
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
$992,151Jonah B. Sacha · Oregon Health & Science University · R01 · FY2024 · AI
B-cell repertoire analysis in influenza vaccination and infection
$992,119Hua-Xin Liao · Boston Children'S Hospital · P01 · FY2015 · AI
Recombinant Subunit West Nile Virus Vaccine Development
$992,079Paul M Kaplan · L2 Diagnostics, Llc · U01 · FY2006 · AI
Northwestern University O'Brien Kidney National Resource Center
$992,052Susan E Quaggin · Northwestern University At Chicago · U54 · FY2023 · DK
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
$991,947Michelle M. Butler · Microbiotix, Inc · R44 · FY2020 · AI
PEDIATRIC AIDS CLINICAL TRIAL UNIT
$991,911Univ Of Massachusetts Med Sch Worcester · U01 · FY2004 · AI
Design of Antigenically-Specific Probes for Sera Analysis and MAb Isolation
$991,870Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2017 · AI